Breakthrough insights into cell–cell communication powered by Partillion's Nanovials were spotlighted by Professor Dino Di Carlo, Chair of Bioengineering at UCLA, at Advances in Single Cell & Spatial ...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma ...

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

Epicrispr Biotechnologies CEO Amber Salzman, Ph.D. offers up four imperatives for industry leaders working to develop tomorrows genetic therapies.

Dr Lee Coffey’s research at SETU on gene therapies for a rare neurological disease was inspired by family circumstances.

Single cell gene expression studies often rely on single-cell RNA sequencing (scRNA-seq) alone. While scRNA-seq reveals which genes are turned on, it does not capture protein expression or changes to ...

Essentially all cells in an organism's body have the same genetic blueprint, or genome, but the set of genes that are actively expressed at any given time in a cell determines what type of cell it ...

Krystal Biotech reports positive clinical data for KB408 and KB407, demonstrating safety and efficacy in AATD and cystic fibrosis patients. Krystal Biotech, Inc. has announced promising clinical ...

Our models help scientists predict the results of new and currently impossible experiments to move their science forward much ...

PlantArcBio (TASE: PLNT) is pleased to announce that it has been granted patents in the United States and South Korea for its proprietary DIPPER™ platform, a breakthrough technology designed to ...